Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-03-04 @ 10:25 PM
Study NCT ID:
NCT03817320
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-17
First Post:
2019-01-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Sponsor:
Therapeutic Advances in Childhood Leukemia Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-22
First Submit QC Date:
None
Study First Post Date:
2019-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-07
Results First Submit QC Date:
None
Results First Post Date:
2025-06-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-30
Last Update Post Date:
2025-06-17
Last Update Post Date Type:
ACTUAL